Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval

por Sheng, Wang-Huei, Chang, Sui-Yuan, Hsieh, Ming-Ju, Ieong, Si-Man, Chang, Shan-Chwen
Publicado 2023

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations

por Cheng, Aristine, Hsieh, Ming-Ju, Chang, Sui-Yuan, Ieong, Si-Man, Cheng, Chien-Yu, Sheng, Wang-Huei, Chang, Shan-Chwen
Publicado 2023

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

por Sheng, Wang-Huei, Wang, Chung-Cheng, Chu, Ching-Chi, Lin, Yueh-Juh, Chang, Sui-Yuan, Ieong, Si-Man, Chang, Shan-Chwen
Publicado 2023

Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021

por Lin, Kuan-Yin, Hsieh, Ming-Ju, Chang, Sui-Yuan, Ieong, Si-Man, Cheng, Chien-Yu, Sheng, Wang-Huei, Chang, Shan-Chwen
Publicado 2022

Proteins rather than mRNAs regulate nucleation and persistence of Oskar germ granules in Drosophila

por Curnutte, Harrison A., Lan, Xinyue, Sargen, Manuel, Ao Ieong, Si Man, Campbell, Dylan, Kim, Hyosik, Liao, Yijun, Lazar, Sarah Bailah, Trcek, Tatjana
Publicado 2023

Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine

por Sheng, Wang-Huei, Ieong, Si-Man, Lin, Pin-Hung, Hsieh, Ming-Ju, Yang, Hung-Chih, Pan, Ching-Fu, Chao, Tai-Ling, Chang, Sui-Yuan, Chang, Shan-Chwen
Publicado 2023

Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets

por Yu, Pei-Chen, Huang, Chen-Hao, Kuo, Chih-Jung, Liang, Po-Huang, Wang, Lily Hui-Ching, Pan, Max Yu-Chen, Chang, Sui-Yuan, Chao, Tai-Ling, Ieong, Si-Man, Fang, Jun-Tung, Huang, Hsuan-Cheng, Juan, Hsueh-Fen
Publicado 2022

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination

por Sheng, Wang-Huei, Chang, Sui-Yuan, Lin, Pin-Hung, Hsieh, Ming-Ju, Chang, Hao-Hsiang, Cheng, Chien-Yu, Yang, Hung-Chih, Pan, Ching-Fu, Ieong, Si-Man, Chao, Tai-Ling, Chen, Jang-Pin, Cheng, Shu-Hsing, Chang, Shan-Chwen
Publicado 2022

Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19

por Liu, Wang-Da, Wang, Jann-Tay, Chao, Tai-Ling, Ieong, Si-Man, Tsai, Ya-Min, Kuo, Po-Hsien, Tsai, Ming-Jui, Chen, Yi-Jie, Li, Guei-Chi, Ho, Shu-Yuan, Chen, Hui-Hou, Huang, Yu-Shan, Hung, Chien-Ching, Chen, Yee-Chun, Chang, Sui-Yuan, Chang, Shan-Chwen
Publicado 2022

A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

por Chang, Yi‐Chung, Yang, Chi‐Fan, Chen, Yi‐Fen, Yang, Chia‐Chun, Chou, Yuan‐Lin, Chou, Hung‐Wen, Chang, Tein‐Yao, Chao, Tai‐Ling, Hsu, Shu‐Chen, Ieong, Si‐Man, Tsai, Ya‐Min, Liu, Ping‐Cheng, Chin, Yuan‐Fan, Fang, Jun‐Tung, Kao, Han‐Chieh, Lu, Hsuan‐Ying, Chang, Jia‐Yu, Weng, Ren‐Shiuan, Tu, Qian‐Wen, Chang, Fang‐Yu, Huang, Kuo‐Yen, Lee, Tong‐Young, Chang, Sui‐Yuan, Yang, Pan‐Chyr
Publicado 2022